Lactose (India) Ltd
Lactose (India) Ltd (524202): company summary
Lactose (India) Ltd (524202) is a micro-cap Healthcare company valued at ₹127 crore operating in Pharmaceuticals on the NSE and BSE.
Lactose (India) Ltd (524202) is a micro-cap Healthcare company valued at ₹127 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 35.3% a year over three years; profit grew 94.9% a year, ahead of revenue — margins are expanding. Return on equity is 9.8%.
- Valuation multiples
- The stock trades at 21.0 times earnings, a discount to the Healthcare median of 32.5, 1.96 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (10.0), but held back by valuation (3.6). Scored on 4 of 5 measures.
DocStoX score
Medium confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Profit compounding 95% a year
- Revenue compounding 36% a year
- Profitable in all of the last 5 years
- Small ₹127 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Lactose (India) Ltd’s valuation
Free deep-dive tools · no sign-up
Lactose (India) Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Lactose (India) Ltd with peers
Related tools & concepts
Value Lactose (India) Ltd with the ratios and calculators DocStoX uses in its analysis.

